Skin cancers are rising rapidly and melanoma is now at the highest level in the UK since records began. A delay in diagnosis, or misdiagnosis, can have a devastating impact. Early diagnosis is essential.
2023
Dr Weiss on the Ongoing Investigation of Tebentafusp With or Without Pembrolizumab in Non-Uveal Melanoma
Sarah Weiss, MD, discusses the ongoing phase 2/3 TEBE-AM trial of tebentafusp with or without pembrolizumab in a subset of pretreated patients with non-uveal melanoma.
New lipid nanoparticle-mRNA therapy combats melanoma in mouse models
Illustration of the closing of the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and cell therapy (CATCH). Credit: Dong et al., Nature Nanotechnology
Screening Won’t Solve Racial Disparities in Melanoma Outcomes, Study Suggests
PITTSBURGH — Increased skin cancer screening in individuals with skin of color is not sufficient to address racial disparities in melanoma survival rates, according to a new JAMA Dermatology study by UPMC and University of Pittsburgh researchers.